Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.230NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.535NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
A.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
A.24NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.564.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.345NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.53NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.450NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.334NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.589NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.335NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.169NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.43NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.42NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AE.4NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.75NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.51NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.106NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
D.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.593NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.345NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23143.5US
AY.71 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.2US
BE.4.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.2US
BQ.1.1.57NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
JN.5.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
EG.5.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
BQ.1.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
KT.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
AY.37 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
KP.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
XBB.1.47.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
XBB.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
B.1.1.109NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
BQ.1.11.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
C.36ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-23179.8Japan
BE.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23210.7Germany
B.1.1.284NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23210.7Germany
BA.5.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23231.3China
BA.5.2.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23259.5US
KF.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23259.5US
JN.1.48.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23259.5US
B.1.336NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
GA.4.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
B.1.619.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
B.1.631NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
B.1.348NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
BF.6NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
EK.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
AY.94 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
B.1.563NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23275.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used